Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.55 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.55 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | LCK | P06239 | 1/20 | 0.53 |
| ▸ | PPARD | Q03181 | 1/20 | 0.53 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.53 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.53 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.50 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.50 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.50 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.47 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.47 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.42 |
| ▸ | BLM | P54132 | 1/20 | 0.42 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2854830 | 1.00 | GPR84 (0.55) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL7006048 | 1.00 | GPR84 (0.55) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL3852448 | 1.00 | GPR84 (0.55) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL5530871 | 1.00 | GPR84 (0.55) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL6930290 | 1.00 | GPR84 (0.55) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL351779 | 1.00 | GPR84 (0.55) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL308689 | 1.00 | GPR84 (0.55) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL3116423 | 1.00 | GPR84 (0.55) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL18221941 | 1.00 | GPR84 (0.55) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL871399 | 1.00 | GPR84 (0.55) | GPR84FFAR1MAPTLCKPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025069894-A1 | SCOURING AGENT COMPOSITION, METHOD FOR PRODUCING SCOURED FIBER, AND METHOD FOR SCOURING FIBER | 松本油脂製薬株式会社 | 2025-04-03 | — | — | WO | disclosed |
| WO-2024080156-A1 | COSMETIC FOR PUMP FOAMER | 株式会社 資生堂 | 2024-04-18 | — | — | WO | disclosed |
| CN-117279612-A | Cosmetic product | 株式会社资生堂 | 2023-12-22 | — | — | CN | disclosed |
| EP-3644948-B1 | ANHYDROUS SOLID COMPOSITION COMPRISING AN ISETHIONIC ACID DERIVATIVE, A GLUTAMIC ACID DERIVATIVE, AN AMPHOTERIC SURFACTANT AND FILLERS | OREAL (FR) | 2023-09-13 | — | — | EP | disclosed |
| CN-115725201-A | Cleaning liquid and liquid set for ink jet recording apparatus | 京瓷办公信息系统株式会社 | 2023-03-03 | — | — | CN | disclosed |
| WO-2022259877-A1 | COSMETIC PREPARATION | 株式会社 資生堂 | 2022-12-15 | — | — | WO | disclosed |
| CN-111699212-B | Polyester film for dry film resist base material | 三菱化学株式会社 | 2022-11-18 | — | — | CN | disclosed |
| US-20210137800-A1 | ANHYDROUS SOLID COMPOSITION COMPRISING AN ISETHIONIC ACID DERIVATIVE, A GLUTAMIC ACID DERIVATIVE, AN AMPHOTERIC SURFACTANT AND FILLERS | L'OREAL (FR) | 2021-05-13 | — | — | US | disclosed |
| EP-3644948-A1 | ANHYDROUS SOLID COMPOSITION COMPRISING AN ISETHIONIC ACID DERIVATIVE, A GLUTAMIC ACID DERIVATIVE, AN AMPHOTERIC SURFACTANT AND FILLERSANHYDROUS SOLID COMPOSITION COMPRISING AN ISETHIONIC ACID DERIVATIVE, A GLUTAMIC ACID DERIVATIVE, AN AMPHOTERIC SURFACTANT AND FILLERS | L'Oréal (FR) | 2020-05-06 | — | — | EP | disclosed |
| CN-110831568-A | Anhydrous solid composition comprising isethionic acid derivative, glutamic acid derivative, amphoteric surfactant and filler | 莱雅公司 | 2020-02-21 | — | — | CN | disclosed |
| EP-1144580-A2 | TRANSPARENT/TRANSLUCENT LIQUID ENZYME COMPOSITIONS IN CLEAR BOTTLES COMPRISING ANTIOXIDANTS | UNILEVER N.V. (NL) | 2001-10-17 | — | — | EP | disclosed |
| US-6296999-B1 | LIGHT INSENSITIVE BLACK AND WHITE THERMOGRAPHIC MATERIAL, MULTILAYER POLYMER ON SUBBING LAYER AND HEAT SENSITIVE ELEMENT ON SUPPORT | AGFA-GEVAERT (BE) | 2001-10-02 | — | — | US | disclosed |
| US-6284442-B1 | PRINTS ENABLE RELIABLE DIAGNOSIS | AGFA-GEVAERT (BE) | 2001-09-04 | — | — | US | disclosed |
| WO-2000036062-A2 | TRANSPARENT/TRANSLUCENT LIQUID ENZYME COMPOSITIONS IN CLEAR BOTTLES COMPRISING ANTIOXIDANTS | UNILEVER N.V. (NL) | 2000-06-22 | — | — | WO | disclosed |
| EP-1004929-A1 | Black and white monosheet thermographic recording material with improved diagnostic capability | AGFA-GEVAERT N.V. (BE) | 2000-05-31 | — | — | EP | disclosed |
| EP-0595686-B1 | Process for pickling steel materials | LORRAINE LAMINAGE (FR) | 1999-04-21 | — | — | EP | disclosed |
| EP-0903627-A1 | Subbing layers for use with thermographic materials | AGFA-GEVAERT N.V. (BE) | 1999-03-24 | — | — | EP | disclosed |
| EP-0595686-A1 | Process for pickling steel materials | SOLLAC (FR) | 1994-05-04 | — | — | EP | disclosed |
| EP-0570383-A1 | PROCESS FOR PREPARING SOLID BETAINES. | ETHYL CORP (US) | 1993-11-24 | — | — | EP | disclosed |
| WO-1992013825-A1 | PROCESS FOR PREPARING SOLID BETAINES | ETHYL CORPORATION (US) | 1992-08-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210137800-A1 | ANHYDROUS SOLID COMPOSITION COMPRISING AN ISETHIONIC ACID DERIVATIVE, A GLUTAMIC ACID DERIVATIVE, AN AMPHOTERIC SURFACTANT AND FILLERS | S100A4, KRT18, S100P | GPR84 1171/4885FFAR1 1050/4885MAPT 1829/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.